Takara Bio Balance Sheet Health
Financial Health criteria checks 6/6
Takara Bio has a total shareholder equity of ¥111.5B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥121.8B and ¥10.2B respectively. Takara Bio's EBIT is ¥873.0M making its interest coverage ratio -4.5. It has cash and short-term investments of ¥38.0B.
Key information
0%
Debt to equity ratio
JP¥0
Debt
| Interest coverage ratio | -4.5x |
| Cash | JP¥37.97b |
| Equity | JP¥111.51b |
| Total liabilities | JP¥10.24b |
| Total assets | JP¥121.75b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4974's short term assets (¥61.0B) exceed its short term liabilities (¥7.8B).
Long Term Liabilities: 4974's short term assets (¥61.0B) exceed its long term liabilities (¥2.4B).
Debt to Equity History and Analysis
Debt Level: 4974 is debt free.
Reducing Debt: 4974 had no debt 5 years ago.
Debt Coverage: 4974 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4974 has no debt, therefore coverage of interest payments is not a concern.